/PRNewswire/ The "Microfluidics to Address Pandemics - SARS-CoV-2 and Beyond" training has been added to ResearchAndMarkets.com s offering. The SARS-CoV-2.
/PRNewswire/ The "Microfluidics to Address Pandemics - SARS-CoV-2 and Beyond" training has been added to ResearchAndMarkets.com s offering. The SARS-CoV-2.